logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Glykon Technologies Group, LLC


USPTO Granted Patents = 16

% Expired Patents = 6.3


Trademarks = 1

Forward Citations = 15

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Daniel E Clouatre (12 out of 13 patents)

silverMedal Dallas L Clouatre (12 out of 18 patents)

bronzeMedal Brad J Douglass (5 out of 12 patents)

4.  Nimpan Bangun (2 out of 3 patents)

5.  James M Dunn (2 out of 15 patents)

6.  Alex Moffett (1 out of 1 patent)

7.  Parag Shah (1 out of 1 patent)


16 patents:

1. 11957649 - Methods and pharmaceutical preparations for elevating ketone utilization (2024-04-16),
2. 11795187 - Hydroxycitric acid metal heterocyclic compounds with covalent characteristics (2023-10-24),
3. 11766415 - Reducing triglyceride levels and cortisol levels with pharmaceutical preparations (2023-09-26),
4. 11744814 - Methods and pharmaceutical preparations for elevating blood hemoglobin and oxygen saturation levels with hydroxycitric acid (2023-09-05),
5. 11219610 - Bolus dose of hydroxycitric acid with glycerol (2022-01-11),
6. 11066423 - Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same (2021-07-20),
7. 10624868 - Bolus dose of hydroxycitric acid with glycerol (2020-04-21),
8. 10561630 - Hydroxycitric acid compounds and capsule liquid delivery (2020-02-18),
9. 10376483 - Bolus dose of hydroxycitric acid with glycerol (2019-08-13),
10. 10006079 - Method for establishing the anti-diabetic potential of bitter melon (2018-06-26),
11. 9993448 - Bolus dose of hydroxycitric acid with glycerol (2018-06-12),
12. 9789076 - Bolus dose of hydroxycitric acid with glycerol (2017-10-17),
13. 8394856 - (-)-Hydroxycitric acid for controlling inflammation (2013-03-12),
14. 8367864 - Dimeric double metal salts of (−)-hydroxycitric acid, methods of making and uses of same (2013-02-05),
15. 7189416 - Method for stable and controlled delivery of (-)-hydroxycitric acid (2007-03-13),
Company Overview
Glykon Technologies Group, LLC, based in Seattle, WA, specializes in innovative solutions within the biotechnology sector. The company focuses on developing advanced technologies aimed at enhancing drug delivery systems and improving therapeutic outcomes. With a commitment to research and development, Glykon leverages cutting-edge methodologies to address complex challenges in healthcare. Their expertise spans various domains, including biopharmaceuticals and medical devices, positioning them as a key player in the evolving landscape of life sciences.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#121 in Seattle, WA

#434 in Washington

#19,907 in US

#37,788 in the World

Seattle, WA (US)
Seattle, WA, United States of America

Glykon Technologies Group, LLC

Forward Citations = 15

7 inventors:

goldMedal Daniel E Clouatre (12 out of 13 patents)

silverMedal Dallas L Clouatre (12 out of 18 patents)

bronzeMedal Brad J Douglass (5 out of 12 patents)

4.  Nimpan Bangun (2 out of 3 patents)

5.  James M Dunn (2 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glykon Technologies Group, LLC. Retrieved from https://idiyas.com/company/glykon-technologies-group

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…